MENU

Fox Chase Cancer Center Department Radiation Oncology Resident Research Publications

The following are publications in peer-reviewed journals or book chapters written by Fox Chase residents during their residency in the past 5 years on which they were the first authors:

2015

Churilla TM, Egleston B, Bleicher R, Dong Y, Meyer J, Anderson, P. Disparities in the Local Management of Breast Cancer in the United States according to Health Insurance Status. The Breast Journal. (Accepted)

M. Johnson, T. Li, A. Kutikov, M. Sobczak, M. Smaldone, E. Horwitz.  “Toxicity Analysis of Lymph Node Irradiation for Prostate Cancer Patients Treated with IMRT.”  Practical Cancer and Prostatic Disease, manuscript in review.

Martin JM, Li T, Johnson ME, Murphy CT, Howald AG, Smaldone MC, Kutikov A, Chen DYT, Viterbo R, Greenberg RE, Uzzo RG, Horwitz EM, (2014) “Utilization of Post-Prostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center” Published in Journal of the National Comprehensive Cancer Network (JNCCN), 2015, PMID# 25964638

Martin JM, Galloway TJ, “Evaluation and Management of Head and Neck Squamous Cell Carcinoma of Unknown Primary,” Surgical Oncology Clinics of North America July 2015 24(3); 579-591 PMID:25979401

Martin JM, Handorf EA, Cherian G, Buyyounouski MK, Chen DY, Kutikov A, Price, RA, Johnson ME, Horwitz EM, “Comparison of Testicular Dose Delivered by Intensity-Modulated Radiation Therapy(IMRT) and Volumetric-Modulated Arc Therapy(VMAT) in Prostate Cancer Patients,” Medical Dosimetry Jan 2015: Epub. PMID: 25595491

Murphy CT, Galloway TJ, Handorf EA, Wang LS, Mehra R, Fleider DB, Ridge JA (2015) “The Survival Impact of Increasing Time to Treatment Initiation for Patients with Head and Neck Cancer in the United States” In Press, Journal of Clinical Oncology

Murphy CT, Devarajan K, Wang LS, Mehra R, Fundakowski C, Ridge JA, Galloway TJ (2015) “Assessment of the Prognostic Utility of Pre-Treatment Tumor Growth Rate as a Temporal Biomarker in Oropharyngeal Cancer Treated with Definitive Radiation Therapy” In Press, Oral Oncology

Murphy CT, Li T, Wang LS, Obeid EI, Bleicher RJ, Eastwick G, Johnson ME, Hayes SB, Weiss SE, Anderson PR “Comparison of Adjuvant Radiation Therapy Alone versus Radiation Therapy and Endocrine Therapy in Elderly Women with Early Stage, Hormone-Receptor Positive Breast Cancer Treated with Breast-Conserving Surgery” Published in Clinical Breast Cancer, 2015, PMID# 25861716

Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. “Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancer.” Practical Radiation Oncology. Accepted. Manuscript in Press.

Shaikh T, Zaki MA, Dominello MM, Handorf E, Konski AA, Cohen SJ, Shields A, Philip P, Meyer JE.  “Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.” Acta Oncologica. 2015 Nov 19:1-6. In Press. (PMID: 26581671)

Shaikh T, Thomay A, Ruth KJ, Cohen SJ, Meyer JE. “Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.” J Surg Oncol. 2015 Oct 2. In Press. (PMID: 26430952)

Shaikh T, Tam TY, Li T, Hayes SB, Goldstein L, Bleicher R, Boraas M, Sigurdson E, Ryan PD, Anderson, PA. “Multifocal and multicentric breast cancer is associated with increased local recurrence regardless of surgery.” Breast J. 2015 Mar-Apr;21(2):121-6. (PMID: 25597248)

Shaikh T, Handorf EA, Murphy CT, Kutikov A, Uzzo RG, Hallman MA, Horwitz EM, Smaldone MC (2015) “Contemporary Trends in the Utilization of Radiation Therapy in Patients with Renal Cell Carcinoma” In Press, Urology

Wang LS, Murphy CT, Ruth KJ, Zaorsky NG, Smaldone MC, Sobczak ML, Kutikov A, Viterbo R, Horwitz EM (2014) “Impact of Obesity on Outcomes After Definitive Dose Escalated Intensity Modulated Radiation Therapy for Localized Prostate Cancer” Published in Cancer, 2015, PMID# 26033633

Zaorsky NG, Li T, Turaka A, Chen DYT, Horwitz EM, Buyyounouski MK. Interval to biochemical failure is prognostic for distant metastases after salvage radiation therapy for prostate cancer. Journal of Radiation Oncology. 2015.

Zaorsky NG, Palmer JD, Hurwitz MD, Keith SW, Dicker AP, Den RB. What is the ideal radiotherapy dose to treat prostate cancer?  A meta-analysis of biologically equivalent dose escalation.  Radiotherapy and Oncology. 2015. 2015 Jun;115(3):295-300. doi: 10.1016/j.radonc.2015.05.011.

Zaorsky NG, Meng MB, Deng L, Wang HH, Chao J, Zhao LJ, Yuan ZY, Ping W. Pericytes: a double-edged sword in cancer therapy.  Future Oncology. 2015;11(1):169-79.

Zaorsky NG, Hallman MA, Smaldone MC. Radiation therapy to the primary tumor in locally advanced prostate cancer is not “closing the barn door after the horse has bolted.” Annals of Translational Medicine. 2015.

Zaorsky NG, Horwitz EM. Chapter 43: Brachytherapy for prostate cancer. Prostate Cancer: Science and Clinical Practice. Mydlo JH, Godec CJ (Eds.). 399-412. ISBN: 9780128000779.

Zaorsky NG, Shaikh TA, Handorf E, Eastwick G, Hesney A, Scher ED, Jones RT, Showalter TN, Avkshtol V, Rice SR, Horwitz EM, Meyer JE. What are medical students in the United States learning about radiation oncology? Results of a multi-institutional survey. International Journal of Radiation Oncology Biology and Physics. 2015.

Zaorsky NG, Meng MB, Wang H, Jiang C, Qian D, Zhao L, Yuan Z, Ping W. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma.  Onco Targets Ther. 2015 Feb 13(8):437-44.

Zaorsky NG, Hurwitz MD, Dicker AP, Showalter TN, Den RB. Is robotic arm stereotactic body radiation therapy “virtual high dose rate brachytherapy” for prostate cancer?  An analysis of comparative effectiveness using published data. Expert Rev Med Devices. 2015 May;12(3):317-27.

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. American College of Radiology appropriateness criteria:  external beam radiation therapy treatment planning for clinically localized prostate cancer.   Int J Radiat Oncol Biol Phys.  2016.

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. Case vignettes for the American College of Radiology appropriateness criteria external beam radiation therapy treatment planning for clinically localized prostate cancer.   Int J Radiat Oncol Biol Phys.  2016.

 

2014... Expand